Veracyte to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference

Rhea-AI Summary

Veracyte (Nasdaq: VCYT) will participate in a fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference on Tuesday, September 15, 2026, at 7:00 a.m. Eastern Time. A live audio webcast and a 90-day replay will be accessible via the company’s investor relations website.

Market Context

A prior conference announcement produced a 0.11% reaction, providing the closest platform comparison...

Analysis

A prior conference announcement produced a 0.11% reaction, providing the closest platform comparison. The current notice was similarly logistical; recent Net Selling insider activity was the main additional risk to monitor.

Key Figures

Conference edition: 24th Presentation date: September 15, 2026 Presentation time: 7:00 a.m. Eastern Time +1 more

4 metrics

Conference edition 24th Morgan Stanley Global Healthcare Conference

Presentation date September 15, 2026 Fireside chat

Presentation time 7:00 a.m. Eastern Time September 15, 2026

Webcast replay 90 days After the live presentation broadcast

Historical Context

5 past events · Latest: Jul 30 (Positive)

Pattern 5 events

Date	Event	Sentiment	24h Move	Catalyst
Jul 30	Q2 earnings report	Positive	-22.5%	Revenue growth, profitability and raised full-year guidance were followed by a negative reaction.
Jul 28	Investor conference participation	Neutral	+0.1%	The company announced participation in two upcoming investor conference fireside chats.
Jul 09	Earnings date announcement	Neutral	-3.9%	Veracyte scheduled its second-quarter results release and accompanying conference call.
Jun 01	Product launch	Positive	+4.0%	Veracyte announced the U.S. commercial launch of its Prosigna Breast Test.
May 29	Phase III clinical data	Positive	-3.4%	OPTIMA results reported chemotherapy avoidance alongside comparable five-year cancer-free survival.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Positive operating and clinical announcements produced mixed reactions, including a -22.52% decline after Q2 results.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SOUTH SAN FRANCISCO, Calif., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today announced it will participate in a fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference on Tuesday, September 15, 2026, at 7:00 a.m. Eastern Time.

A live audio webcast of the company’s presentation will be available by visiting Veracyte’s website at http://investor.veracyte.com/events-presentations. A replay of the webcast will be available for 90 days after the live presentation broadcast.

About Veracyte

Veracyte (Nasdaq: VCYT) is a global diagnostics company with a vision to transform cancer care for patients around the world. The company’s molecular tests assess the unique biology of each patient’s tumor to help clinicians answer essential questions about cancer care. Veracyte’s Diagnostics Platform combines broad genomic and clinical data, advanced bioinformatics and AI, and a powerful evidence-generation engine to support continued innovation and pipeline development. The company’s portfolio includes the Afirma® Genomic Sequencing Classifier test, Decipher® Bladder Genomic Classifier test, Decipher® Prostate Genomic Classifier test, Prosigna® Breast Risk of Recurrence test, and the TrueMRD™ Monitoring Test for MIBC. For more information, visit Veracyte’s website or follow the company on LinkedIn or X (Twitter).

Investors:
Kelly Gura
investors@veracyte.com

Media:
Molly Cornbleet
media@veracyte.com
+1-650-351-8780

FAQ

When will Veracyte (VCYT) present at the Morgan Stanley 24th Annual Global Healthcare Conference in 2026?

Veracyte will present in a fireside chat on Tuesday, September 15, 2026, at 7:00 a.m. Eastern Time. According to Veracyte, investors can access the live audio webcast through the company’s investor relations events and presentations webpage.

How can investors listen to Veracyte’s (VCYT) Morgan Stanley 2026 healthcare conference webcast?

Investors can listen via a live audio webcast on Veracyte’s investor relations website at investor.veracyte.com/events-presentations. According to Veracyte, the webcast will cover the company’s fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference.

Will a replay of Veracyte’s (VCYT) Morgan Stanley 2026 conference presentation be available?

Yes, a replay of the webcast will be available for 90 days after the live broadcast. According to Veracyte, investors can access this replay through the same events and presentations section of the company’s investor relations website.

What type of session is Veracyte (VCYT) holding at the Morgan Stanley 24th Annual Global Healthcare Conference?

Veracyte will participate in a fireside chat session at the conference. According to Veracyte, this moderated discussion format will be available to investors through a live audio webcast and a 90-day replay online.

Where can I find details on Veracyte’s (VCYT) upcoming investor webcasts and conference appearances?

Details on Veracyte’s investor webcasts and conferences are available on its investor relations events and presentations page. According to Veracyte, the Morgan Stanley 2026 conference webcast and replay links will be posted in this section.